
2026-02-12
Inkcazelo yeMeta
Fumanisa indlela iSalmon PDRN exhasa ngayo ukulungiswa kolusu ngokukhawuleza, ukubuyiswa komqobo, kunye nokubuyisela emva kwenkqubo. Ilungele ukwakheka kolusu olunobuntununtunu, olune-acne, ukudumba, kunye nokuguga. Ixhaswa yinkqubo kunye nobungqina bekliniki.
Kumhlaba ovela ngokukhawuleza wokhathalelo lwesikhumba oluhlaziyiweyo, izithako ezimbalwa ziye zenza umdla wesayensi kunye norhwebo njengoko ISalmon PDRN (Polydeoxyribonucleotide) .
Isekwe ekuqaleni kwicandelo lezonyango lokuphulukiswa kwesilonda kunye nokuvuselelwa kwezicubu, iSalmon PDRN iye yawela ngokukhawuleza kwindawo yokuthambisa kunye ne-cosmeceutical. Kubaqulunqi kunye nabaphuhlisi bemveliso ekujoliswe kuyo ukuchacha emva kwenkqubo, ulusu olubuthathaka, iimeko ezinobuqhophololo, kunye nolusu olugugayo, I-PDN inikezela ngendibaniselwano enqabileyo: Ukuphumelela okuqhutywa ngumatshini kunye ne-biocompatibility ekhethekileyo.
Eli nqaku libonelela ngombono obanzi weSalmon PDRN-ukusuka kwindlela yayo yokusebenza ukuya kwizikhokelo zokuqulunqa ezisebenzayo-ekuxhobisa ngolwazi lokuphuhlisa isizukulwana esilandelayo ngokuzithemba. ukulungiswa kwesikhumba kunye neemveliso zokuvuselela umqobo.
I-Polydeoxyribonucleotide (PDRN) yipolymer ephuma kwi-DNA, ngokuqhelekileyo itsalwa kwiiseli ze-salmon zesidoda. Ubume bayo bemolekyuli buneziqhekeza ze-DNA ezinobunzima obuphantsi (50-2000 kDa), ezihambelana ngokumangalisayo neDNA yomntu.
Amandla okuhlaziya eSalmon PDRN alele kubudlelwane bayo A₂A i-adenosine receptor. Kwisicelo se-topical okanye se-intradermal, i-PDRN ibophelela ngokukhethiweyo kwi-A₂A receptors kwi-fibroblasts, i-keratinocytes, kunye neeseli ezivuthayo, ezibangela i-cascade yeempawu zokulungisa:
↑ VEGF (I-Vascular Endothelial Growth Factor): Ukukhuthaza i-angiogenesis, ukuphucula i-oksijini kunye nokunikezelwa kwezondlo kwizicubu ezonakalisiweyo.
↑ Ukwenziwa kweCollagen: Yenza i-fibroblasts isebenze ukuvelisa uhlobo lwe-I kunye ne-III i-collagen, ibuyisela ingqibelelo ye-matrix ye-dermal.
↓ Iicytokines ezikwaziyo ukudumba: Ukunciphisa i-IL-6 kunye ne-TNF-α, ukukhawuleza isisombululo sokuvuvukala.
Esi senzo simbini-ngaxeshanye ipro-regenerative kunye ne-anti-inflammatory-uhlula i-PDRN kwizithako zendlela enye ezifana neepeptides okanye izinto zokukhula.
Ukuthathwa okungundoqo kubenzi befomula: I-PDRN ayipheleli nje “ukuthomalalisa” okanye “ukuthambisa”—it ifundisa ngenkuthalo iiseli zolusu ukuba zizilungise.
Ngokusekwe kubungqina beklinikhi bangoku kunye nokutsalwa kwentengiso, iSalmon PDRN ibonisa ukusebenza okugqwesileyo kuzo zonke iithagethi ezine ezicacileyo zokuyila.
Ulusu olubuthathaka lubonakaliswa yi-stratum corneum ebuthathaka kunye nokuvuvukala okungapheliyo kwibakala eliphantsi. I-PDRN ilungisa zombini oonobangela:
Ukukhawulezisa ukuhlukana kwe-keratinocyte, ukwakha kwakhona umqobo womzimba.
Ukunciphisa umsebenzi we-TRPV1 we-receptor, ukunciphisa ukuphazamiseka kwe-neurosensory.
Ulwakhiwo olufanelekileyo: Ilungele iiserum zemihla ngemihla kunye neekhrimu zokubuyisela ubusuku ezijolise kwisikhumba esisebenzayo, esibomvu.
Ngokungafaniyo neearhente zemveli ezichasene ne-acne ezigxile kulawulo lwe-sebum okanye ekuthinteleni ibhaktheriya, iPDRN ijolise ekulawuleni i-sebum. isigaba sokudumba izilonda ze-acne.
Yehlisa i-perilesional erythema.
Inciphisa umjikelo wokuphilisa iipapules kunye neepustules.
Inciphisa umngcipheko we-post-inflammatory hyperpigmentation (PIH).
Ulwakhiwo olufanelekileyo: Unyango lwamabala e-post-acne, i-essences epholileyo, kunye neegels ezipholisayo emva kokukhupha.
Ngokunyuka "kwebhayisikile yesikhumba" kunye nonyango lweklinikhi (i-laser, i-microneedling, i-chemical peels), i-post-procedure skincare ibe yinqanaba eliphezulu lokukhula. I-PDRN ifaneleke ngokukodwa apha:
Iklinikhi iboniswe ukunciphisa ubude be-post-laser erythema ngama-30-40%.
Ixhasa ukuphindaphinda kwe-epithelialization ngaphandle kokuphazamisa i-cascade yokupholisa inxeba.
I-non-oclusive, ifanelekile kwisicelo ngokukhawuleza emva kokuphazamiseka komqobo.
Ulwakhiwo olufanelekileyo: Iimaski zokubuyisela emva kwenkqubo, ii-ampoules zokusetyenziswa kobuchwephesha, kunye nee-balm emva kokunyanga.
Ukukwazi kwePDRN ukuvuselela umsebenzi we-fibroblast kunye ne-ECM synthesis ibeka njengenye indlela enyanzelisayo okanye ehambelana ne-retinoids kunye neepeptides-ngaphandle kokucaphuka.
Ukwandisa ubukhulu besikhumba kwiiveki ezi-8-12 zokusetyenziswa rhoqo.
Ukuphucula ukuqina kwesikhumba kunye nokubonakala komgca ocolekileyo.
Ifanelekile kwiiprotocol zexesha elide "zokuvuselela ukuguga".
Ulwakhiwo olufanelekileyo: Iiserum ezichasayo, iikhrimu eziqinisayo, kunye ne "booster" zigxininisa.
Kubaphuhlisi bemveliso kunye namaqela e-R&D, ukutshintsha ukusuka "kwizithako" ukuya "kwifomula egqityiweyo" kufuna ulwazi olusebenzayo. Apha ngezantsi kukho iiparamitha zokwenziwa ezibalulekileyo ze Salmon PDRN powder.
| Uhlobo lwesicelo | INqanaba lokuSebenzisa eliCetyisiweyo |
|---|---|
| Isondlo / Ukhathalelo lwemihla ngemihla | 0.1% - 0.5% |
| Ukulungiswa okunzulu / Ukusetyenziswa kobuchwephesha | 0.5% - 2.0% |
| I-post-procedure / Clinical | 2.0% - 5.0% (phantsi kweliso lonyango) |
Ukunyibilika: I-PDRN inyibilika ngokukhululekileyo emanzini; kucetyiswa ukuba inyibilike kwisigaba samanzi kwi-≤40 ° C.
pH uzinzo: Izinzile kwi-pH 5.0-7.0; ziphephe iimeko ezinobumuncu obugqithisileyo (pH <4.0) ezinokubangela ukungcola.
Uzinzo lweThermal: Inovelwano kubushushu obuphezulu obude (>60°C). Yongeza i-post-emulsification kwi-≤50°C.
I-PDRN idibanisa ngokubambisana ne:
| Udidi lwezithako | Imizekelo | Ingqiqo ye-Synergy |
|---|---|---|
| IiHumectants | Glycerin, Betaine, Hyaluronic acid | Ukomelezwa kwe-hydration + ukulungiswa |
| Iiarhente ezipholisayo | Panthenol, Allantoin, Madecassoside | Iindlela ezongezelelweyo zokuchasa ukudumba |
| Isithintelo lipids | Iikeramidi, iSqualane, iNiacinamide | Ukubuyiselwa kwesakhiwo + inkxaso yomqondiso |
Ugxininiso oluphezulu lwe i-ethanol okanye utywala obunxilisayo -Inokuthi ikhuphe amaqhekeza eDNA.
Yomelele anionic surfactants (SLS/SLES) kwiifomathi zekhefu-zinokuthi ziphazamise ingqibelelo yeemolekyuli.
I-pH ephantsi exfoliants (AHAs / BHAs) kwinqanaba elifanayo - lihluke kwiirejimeni zamanyathelo amaninzi.
Xa uvavanya izithako ezisebenzayo kwiimveliso ezijoliswe ekulungiseni, uvavanyo lokuthelekisa lubalulekile.
| Isithako | Inkqubo yokuqala | Amandla | Ukulinganiselwa |
|---|---|---|---|
| ISalmon PDRN | I-A₂A activation receptor, i-DNA yokulungisa umqondiso | I-Dual anti-inflammatory + regenerative; ilifa leklinikhi elomeleleyo | Iindleko; ifuna ugcino lwetsheyini ebandayo (impahla ekrwada) |
| Centella Asiatica / Madecassoside | Ukuvuselela kwe-TGF-β1, i-collagen synthesis | Isekwe kakuhle; iindleko-esebenzayo | Ukuqala kancinci; ngokuyintloko iyathuthuzela, hayi ukuhlaziya |
| Iipeptides (Ubhedu, iMatrixyl) | Ukubonakalisa i-ECM, ukusebenza kwe-fibroblast | Zininzi izinto; ezinzile | Indlela emxinwa; isiphumo esincinci sokuchasana nokudumba |
| Ii-Exosomes | Unxibelelwano lwe-intercellular, ukudluliselwa kwe-miRNA | Ukuvuselela okunamandla | Ukungaqiniseki kulawulo; ukuguquguquka okuphezulu |
Isigqibo: I-PDRN ikwindawo ekhethekileyo "ephakathi"ukuhlaziya ngakumbi kunezityalo, kuqinisekiswe ngakumbi ngokweklinikhi kuneexosomes.
ISalmon PDRN ayisiyo "isithako esiqhelekileyo." Ukusebenza kwayo kuxhaswa ngamashumi eminyaka yophando lweklinikhi, ngokukodwa ekuphulukiseni amanxeba kunye ne-dermatology.
Ulungiso lwasemva kwelaser: Uphononongo luka-2023 olunobuso obuhlukeneyo lubonise ukuba amacala anyangwe nge-PDRN abonisa i-42% ngokukhawuleza ukusonjululwa kwe-erythema vs.
I-atopic dermatitis: Ukuqulunqwa kwe-Topical PDRN kunciphise i-SCORAD index nge-37% kwiiveki ezi-4 kwizigulane ze-AD ezithambileyo ukuya kwi-moderate.
Ukhuseleko: Njengepolymer ehambelana ne-biocompatible, i-PDRN ayibonisi i-cytotoxicity, i-sensitization potential, okanye i-mutagenicity. Ayicaphukisi nakwi-5.0% yoxinaniso kwiimvavanyo ze-occlusive patch.
Inqaku lamaqela alawulayo: I-PDRN yamkelwa njengesithako sokuthambisa kwi-EU, Korea, nase China (ilindele imvume ye-NMPA yomgangatho otofwayo). INCI igama: Isodium DNA. EC No. 310-127-6.
Imakethi yePDRN yehlabathi kuqikelelwa ukuba iya kukhula kwi- I-CAGR ye-8.9% (2024–2030) , iqhutywa ngu:
Ukunyuka kwemfuno yokhathalelo lwesikhumba "lwezonyango".
Jika uye ngase ukuthintela kunye nokuvuselela ukuchasana nokuguga.
Ukuvela kwe i-vegan / i-PDRN edibeneyo njengenye indlela engenazilwanyana.
Kwiibrendi ezifuna ukungena kolu didi, ukucaca kwekhonkco lokubonelela kubalulekile. Iikhrayitheriya eziphambili zokuthenga zibandakanya:
| Ikhrayitheriya | Inkcazo |
|---|---|
| Ubunyulu | ≥95% (HPLC) |
| Endotoxin | <0.05 EU/mg (yokusetyenziswa ngokutofwayo/ekuhlaselweyo) |
| Ubunzima bemolekyuli | 100–500 kDa (yeyona ilungileyo yokungena kwisihloko) |
| Amaxwebhu | I-COA, i-MSDS, i-Allergen statement, i-Non-GMO |
Ngaba ujonge i-Salmon PDRN ethembekileyo yomthengisi we-powder?
Xa uvavanya amaqabane, beka phambili abavelisi nge Isiqinisekiso se-GMP, ukulandeleka ngokupheleleyo, kwaye inkxaso yokwenziwa kobugcisa.
I-Q1: Ngaba i-Salmon PDRN ifanelekile kwi-vegan okanye i-brand-free brand?
I-PDN yesiNtu iphuma kwizilwanyana (i-salmon). Nangona kunjalo, i-PDN edibeneyo eveliswe ngokuvutshelwa ngoku iyafumaneka kurhwebo, inika enye indlela ethobela i-vegan.
I-Q2: Yintoni ishelufu yobomi be-PDRN powder?
Iinyanga ezingama-24 xa zigcinwe kwi-2-8 ° C, zikhuselwe ekukhanyeni kunye nokufuma.
I-Q3: Ngaba i-PDN inokudibaniswa ne-retinoids?
Ewe, kodwa ngokukhethekileyo kumanyathelo ahlukeneyo (umzekelo, i-PDRN AM, i-retinoid PM) ukuphepha ukungqubana kwe-pH.
I-Q4: Ngaba i-PDN ibangela ukuhlanjululwa?
Hayi. I-PDRN ayikhawulezisi ukuguqulwa kweeseli kwi-comedolytic sense; ixhasa ukulungiswa ngaphandle kokuphazamisa i-stratum corneum.
I-Q5: Uthini umehluko phakathi kwe-PDRN kunye ne-PN (i-Polynucleotide)?
I-PN i-chain-chain, i-cross-linked form ye-PDRN ene-viscosity ephezulu kunye nexesha elide lokuhlala kwe-dermal-ifaneleke ngakumbi kwiifayili ezitofwayo. Kwimixube emixholweni, i-PDRN ephantsi ye-molecular-weight inikeza ukungena okuphezulu.
ISalmon PDRN imele a i-paradigm shift kwi-topical skin repair. Indlela yayo ekhethekileyo-ukwenza kusebenze oomatshini bokuhlaziya umzimba ngokusebenzisa i-A₂A receptor agonism-ibeka kwindawo ekudibanela kuyo i-dermatology kunye ne-cosmeceuticals yokusebenza okuphezulu.
Kubaqulunqi kunye nabanini bebhrendi, ithuba licacile:
Yahlula kwiindidi ezixineneyo "zesikhumba esibuthathaka" kunye ne "post-procedure".
Phakamisa ukusuka ekufumeni okungaphezulu ukuya ekuvuseleleni izicubu zokwenyani.
Bamba imfuno ekhulayo yezithako ezisekelwe kubungqina, ezithembekileyo ngokwezonyango.
Nokuba uphuhlisa i-serum ye-post-laser recovery, i-concentrate anti-aging, okanye isithintelo-someleza ikhrimu yemihla ngemihla, ISalmon PDRN ibonelela ngokusebenza, ukhuseleko, kunye nebali labathengi ukuze baphumelele kwixesha lokuhlaziya isikhumba..